Skip to main content
. 2017 Oct 10;8(18):3657–3666. doi: 10.7150/jca.20053

Table 4.

Incidence of acute treatment-related toxicities

PF group (N = 41)
n (%)
DP group (N = 45)
n (%)
P-value
Leukocytopenia / Neutropenia
Grade 0 2 (4.9) 2 (4.4) 0.000
Grade 1 5 (12.2) 5 (11.1)
Grade 2 26 (63.4) 7 (15.6)
Grade 3 8 (19.5) 5 (11.1)
Grade 4 0 (0.0) 26 (57.8)
Thrombocytopenia
Grade 0 19 (46.3) 17 (37.8) 0.608
Grade 1 11 (26.8) 14 (31.1)
Grade 2 10 (24.4) 7 (20.0)
Grade 3 1 (2.4) 3 (6.7)
Grade 4 0 (0.0) 2 (4.4)
Anaemia
Grade 0 7 (17.1) 2 (4.4) 0.000
Grade 1 24 (58.5) 14 (31.1)
Grade 2 7 (17.1) 27 (60.0)
Grade 3 3 (7.3) 2 (4.4)
Nausea and vomiting
Grade 0 3 (7.3) 1 (2.2) 0.217
Grade 1 21 (51.2) 24 (53.3)
Grade 2 11 (26.8) 18 (40.0)
Grade 3 6 (14.6) 2 (4.4)
Liver enzyme elevation
Grade 0 32 (78.0) 25 (55.6) 0.028
Grade 1 9 (22.0) 20 (44.4)
Oesophagitis
Grade 0 2 (4.9) 0 (0.0) 0.496
Grade 1 13 (31.7) 11 (24.4)
Grade 2 11 (26.8) 15 (33.3)
Grade 3 15 (36.6) 18 (40.0)
Grade 4 0 (0.0) 1 (2.2)
Radiation pneumonitis
Grade 0 30 (73.2) 34 (75.6) 0.436
Grade 1 6 (14.6) 7 (15.6)
Grade 2 1 (2.4) 3 (6.7)
Grade 3 4 (9.8) 1 (2.2)

Note: Acute toxicities were evaluated according to the Common Terminology Criteria for Adverse Events version 3.0 (CTCAE 3.0).